← Back to Search

Corticosteroid

Methylprednisolone Tablet for Hand Injuries

Phase 2 & 3
Waitlist Available
Led By Brian Katt, MD
Research Sponsored by Robert Wood Johnson Barnabas Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial will test the efficacy of steroids in reducing pain and swelling, and improving range of motion and function, in patients with musculoskeletal injuries of the hand.

Eligible Conditions
  • Hand Injuries
  • Finger Injuries

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
MCP, DIP, PIP of digits 2-5: Extension
MCP, DIP, PIP of digits 2-5: Flexion
MCP, DIP, PIP of digits 2-5: abduction
+11 more
Secondary outcome measures
Complications
Edema Measurements
VAS Pain Scale

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Steroid GroupExperimental Treatment1 Intervention
Patients receive 21 tablets of 4 mg methylprednisolone to be taken by mouth over a 6 week taper. Patients will be advised to not take other anti-inflammatory medications like NSAIDs.
Group II: Control GroupActive Control1 Intervention
Patients will recieve standard treatment that focuses on mobilization and stabilization using common techniques like buddy taping and splinting. Pain control will be managed using non-NSAID medications like Tylenol or opioid narcotics when deemed medically necessary.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Methylprednisolone
FDA approved

Find a Location

Who is running the clinical trial?

Robert Wood Johnson Barnabas HealthLead Sponsor
1 Previous Clinical Trials
32 Total Patients Enrolled
Brielle OrthopedicsUNKNOWN
1 Previous Clinical Trials
32 Total Patients Enrolled
University Orthopedics AssociatesUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How is Methylprednisolone Tablet typically employed?

"Methylprednisolone Tablet can be used to improve scalp structure, fight multiple sclerosis, and manage ulcerative colitis."

Answered by AI

Are patients being signed up for this clinical trial at this time?

"Unfortunately, this trial is no longer seeking participants. It was originally posted on September 1st, 2021 but was last updated on August 5th, 2021. There are currently 763 trials actively admitting participants with finger injuries and 155 trials for Methylprednisolone Tablet enrolling participants."

Answered by AI

Are there any other similar Methylprednisolone Tablet studies that have been completed?

"As of now, there are 155 active trials researching Methylprednisolone Tablet with 42 trials in Phase 3. While the majority of the studies for Methylprednisolone Tablet are based in Duarte, California, there are 6734 locations around the world operating trials for Methylprednisolone Tablet."

Answered by AI
Recent research and studies
~17 spots leftby Apr 2025